Many autoimmune conditions have gut involvement, whether through intestinal permeability (leaky gut), microbiome disruption, or direct intestinal immune activation
Results are delivered directly to you
Both are part of a new class of drugs known as GLP-1 receptor agonists, but they have some key differences in how they work and their overall efficacy
Latest developments on GLP-1 patches Various pharmaceutical companies, particularly in South Korea, including Daewoong Pharmaceutical, are working on developing microneedle patches for GLP-1 drugs
occasionally, they may be active at night
Our job is to equip our specialists with the necessary tools to remain competitive without sacrificing quality